Market Niche Target research institutions and contract research organizations focusing on immune repertoire sequencing, immune monitoring, minimal residual disease, and biomarker development, highlighting iRepertoire’s unique diversity and sharing indices to differentiate offerings.

Strategic Partnerships Leverage existing collaborations with Beckman Coulter and iCubate to co-develop and validate protocols, offering bundled solutions that combine kits, sequencing services, and automated workflow capabilities for speed to results.

Automation Advantage Promote automating repertoire amplification and extraction via the iC-processor to entice labs seeking scalable, cost-effective library preparation and end-to-end data analysis within the iRepertoire software pipeline.

Biomarker Focus Position the company as a partner for biomarker discovery and translational research by stressing the data outputs from the diversity and sharing indices for disease signatures, prognosis, and treatment guidance.

Funding & Growth Highlight the startup-to-SMEs growth trajectory with revenue in the sub $10M range as an opportunity for strategic investors or collaborators looking to expand immune repertoire capabilities into clinical and pharmaceutical markets.